DEBIOPHARM INVESTMENT S.A.

The mission of Debiopharm Investment SA is to diversify investments made by Debiopharm Group, a Swiss-based global biopharmaceutical group. This diversification occurs particularly with the Private Equity branch taking minority stakes in innovative IT, Cleantech and ‘Services for Individuals’ startups.

Buoyed by the strong entrepreneurial spirit of the owners, the Private Equity activity is currently developed via direct equity funding in companies not related to the core business in order to enhance investment diversification.
When evaluating investment opportunities, firstly the team and its project are considered.

The investment philosophy entails:
- Minority participation (up to 25% of the capital).
- Long term investment, without horizon output preset but in respect of certain conditions (Strategy, Business Plan, Milestones).
- Active mode: through a presence in the Board of Directors and an involvement in the monitoring of the business.
- Spirit of partnership focusing on exchange, dialogue and experience sharing.